Danimer Scientific, Inc. DNMR
We take great care to ensure that the data presented and summarized in this overview for Danimer Scientific, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding DNMR
View all-
Armistice Capital, LLC New York, NY10.8MShares$32.9 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$14.1 Million0.0% of portfolio
-
David Einhorn Greenlight Capital Inc | New York, Ny2.73MShares$8.34 Million0.14% of portfolio
-
Jefferies Group LLC New York, NY2.67MShares$8.14 Million0.08% of portfolio
-
Invesco Ltd. Atlanta, GA1.95MShares$5.96 Million0.0% of portfolio
-
Jefferies Financial Group Inc. New York, NY1.92MShares$5.85 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.38MShares$4.22 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.22MShares$3.73 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.11MShares$3.38 Million0.0% of portfolio
-
Dme Capital Management, LP New York, NY1.1MShares$3.35 Million0.02% of portfolio
Latest Institutional Activity in DNMR
Top Purchases
Top Sells
About DNMR
Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products for biopolymers, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.
Insider Transactions at DNMR
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2024
|
Allison Leopold Tilley |
BUY
Exercise of conversion of derivative security
|
Direct |
16,611
+50.0%
|
-
|
|
Jun 01
2024
|
Stuart W Pratt |
BUY
Exercise of conversion of derivative security
|
Direct |
16,611
+1.13%
|
-
|
|
Jun 01
2024
|
Cynthia R Cohen |
BUY
Exercise of conversion of derivative security
|
Direct |
18,272
+50.0%
|
-
|
|
Jun 01
2024
|
Gregory W. Hunt |
BUY
Exercise of conversion of derivative security
|
Direct |
23,256
+50.0%
|
-
|
|
Jun 01
2024
|
Richard J Hendrix |
BUY
Exercise of conversion of derivative security
|
Direct |
18,272
+21.11%
|
-
|
|
Jun 01
2024
|
Philip Gregory Calhoun |
BUY
Exercise of conversion of derivative security
|
Direct |
16,611
+5.65%
|
-
|
|
Jun 01
2024
|
John P Amboian |
BUY
Exercise of conversion of derivative security
|
Direct |
26,578
+50.0%
|
-
|
|
Jun 01
2024
|
Isao Noda |
BUY
Exercise of conversion of derivative security
|
Direct |
16,611
+43.95%
|
-
|
|
Feb 07
2024
|
Michael A Hajost Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,076
-14.52%
|
$0
$0.66 P/Share
|
|
Feb 07
2024
|
Michael A Hajost Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34,364
+29.25%
|
-
|
|
Dec 29
2023
|
Scott Tuten Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,926
-5.46%
|
$18,926
$1.02 P/Share
|
|
Dec 29
2023
|
Michael Eric Smith Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,358
-8.85%
|
$28,358
$1.02 P/Share
|
|
Dec 29
2023
|
Phillip D Van Trump Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,926
-5.34%
|
$18,926
$1.02 P/Share
|
|
Nov 28
2023
|
Richard J Hendrix |
BUY
Open market or private purchase
|
Indirect |
50,000
+11.33%
|
$0
$0.93 P/Share
|
|
Nov 28
2023
|
Richard J Hendrix |
BUY
Open market or private purchase
|
Direct |
50,000
+50.0%
|
$0
$0.94 P/Share
|
|
Jun 20
2023
|
Scott Tuten Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
10,000
-2.81%
|
$20,000
$2.74 P/Share
|
|
May 17
2023
|
Scott Tuten Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
10,000
-2.73%
|
$30,000
$3.38 P/Share
|
|
Apr 17
2023
|
Scott Tuten Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
10,000
-2.67%
|
$40,000
$4.26 P/Share
|
|
Mar 17
2023
|
Scott Tuten Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
10,000
-2.6%
|
$20,000
$2.1 P/Share
|
|
Feb 17
2023
|
Scott Tuten Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
10,000
-2.53%
|
$20,000
$2.21 P/Share
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 187K shares |
|---|
| Payment of exercise price or tax liability | 78.3K shares |
|---|